Heartseed Inc.

¥2,700As of Sun 8 Nov 2026, 12:00 UTC
TSE:219AHealthcare
Country Japan
PE (Fwd) •••
TSR 2Y CAGR 28.95%
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.80)
PE TTM —
TSR TTM 55.80%
Mkt cap ¥61.81B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥2,734
1.24%
(39.58%)
Hold 5|3|6|11|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
38.44
40.19
41.88
45.65
12.50%
21.47%
27.12%
31.01%
Revenue¥B
3.396
3.349
3.413
3.531
2.80%
3.34%
(0.64%)
3.75%
Peers (US$392.5M)
Cap (US$)
PE
341.1M
—
240.5M
10.86x
393.9M
203.0x
Capital
TTM
5Y
10Y
Leveragex
3.094
0.011
0.010
EBIT/Intx
1.089
1.192
0.987
Own earn%
(23.77)
(35.42)
(35.41)
Sh yield%
54.25
37.74
38.94
Owners
Insiders/Inst%
10.66
43.85
Short interest%
3.26
SBC / revenue%
1.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
21–32
$1 testx
—
Incr. ROIC%
50